相似文献
1
Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy.
Br J Cancer. 2023 Feb;128(3):419-420. doi: 10.1038/s41416-022-02075-z. Epub 2022 Dec 7.
2
New Approaches for Immune Directed Treatment for Ovarian Cancer.
Curr Treat Options Oncol. 2016 Mar;17(3):14. doi: 10.1007/s11864-016-0389-1.
3
Cancer immunotherapies targeting the PD-1 signaling pathway.
J Biomed Sci. 2017 Apr 4;24(1):26. doi: 10.1186/s12929-017-0329-9.
4
Progress in human tumour immunology and immunotherapy.
Nature. 2001 May 17;411(6835):380-4. doi: 10.1038/35077246.
5
Targeting tumours with genetically enhanced T lymphocytes.
Nat Rev Cancer. 2003 Jan;3(1):35-45. doi: 10.1038/nrc971.
6
Immunotherapies: Exploiting the Immune System for Cancer Treatment.
J Immunol Res. 2018 Mar 14;2018:9585614. doi: 10.1155/2018/9585614. eCollection 2018.
7
Immunologic approaches for the treatment of multiple myeloma.
Cancer Treat Rev. 2017 Apr;55:190-199. doi: 10.1016/j.ctrv.2017.03.010. Epub 2017 Apr 6.
8
From "magic bullets" to specific cancer immunotherapy.
Swiss Med Wkly. 2013 Jan 23;143:w13734. doi: 10.4414/smw.2013.13734. eCollection 2013.
9
Intratumoral immunotherapy: using the tumor as the remedy.
Ann Oncol. 2017 Dec 1;28(suppl_12):xii33-xii43. doi: 10.1093/annonc/mdx683.
10
Current Headway in Cancer Immunotherapy Emphasizing the Practice of Genetically Engineered T Cells to Target Selected Tumor Antigens.
Crit Rev Immunol. 2021;41(1):23-40. doi: 10.1615/CritRevImmunol.2020037044.
本文引用的文献
1
The concept of immune surveillance against tumors. The first theories.
Oncotarget. 2017 Jan 24;8(4):7175-7180. doi: 10.18632/oncotarget.12739.
2
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy.
Cancers (Basel). 2016 Mar 15;8(3):36. doi: 10.3390/cancers8030036.
3
4
AN EXPERIMENTAL COMPARISON OF TRANSPLANTED TUMOR AND A TRANSPLANTED NORMAL TISSUE CAPABLE OF GROWTH.
J Exp Med. 1910 May 1;12(3):344-66. doi: 10.1084/jem.12.3.344.
5
Toward a genetics of cancer resistance.
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):859-63. doi: 10.1073/pnas.0811616106. Epub 2009 Jan 7.
6
Possible host resistance in carcinoma of the breast: a histological study.
Br J Cancer. 1968 Sep;22(3):383-401. doi: 10.1038/bjc.1968.47.
7
A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
Br J Cancer. 1976 Mar;33(3):241-59. doi: 10.1038/bjc.1976.37.
8
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.
Proc Natl Acad Sci U S A. 1977 May;74(5):2121-5. doi: 10.1073/pnas.74.5.2121.
9
Monoclonal antibodies for analysis of the HLA system.
Immunol Rev. 1979;47:3-61. doi: 10.1111/j.1600-065x.1979.tb00288.x.
Zotero 插件